CAS 1369489-71-3

E-7046

CAS : 1369489-71-3

Formule : C₂₂H₁₈F₅N₃O₄

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 483.3880

Ref: IN-DA019GBZ

(S)-4-(1-(3-(Difluoromethyl)-1-Methyl-5-(3-(Trifluoromethyl)Phenoxy)-1H-Pyrazole-4-Carboxamido)Ethyl)Benzoic Acid

CAS : 1369489-71-3

(S)-4-(1-(3-(Difluoromethyl)-1-Methyl-5-(3-(Trifluoromethyl)Phenoxy)-1H-Pyrazole-4-Carboxamido)Ethyl)Benzoic Acid

Degré de pureté : 99%,ee 98%

Masse moléculaire : 483.39g/mol

Ref: 54-PC108639

E7046

CAS : 1369489-71-3

E7046

Degré de pureté : ≥98%

Masse moléculaire : 483.4g/mol

Ref: 54-BUP06705

E7046

CAS : 1369489-71-3

E7046 is a specific, orally bioavailable EP4 antagonist (IC50: 13.5 nM, Ki: 23.14 nM), exhibiting anti-tumor activities.

Formule : C₂₂H₁₈F₅N₃O₄

Degré de pureté : 99.86%

Couleur et forme : Solid

Masse moléculaire : 483.4

Ref: TM-TQ0025

E7046

CAS : 1369489-71-3

E7046 is a potent antitumor agent that belongs to the class of immunomodulators. It has been shown to have immunomodulatory effects in mice with tumor cells, as well as potent anti-tumor activity in mouse and human cervical cancer cell lines. E7046 has also been found to induce collagen production in mice and inhibit collagenase, an enzyme that breaks down collagen. E7046 has also been shown to be effective against HIV infection, which may be due to its ability to inhibit viral replication by inhibiting transcription and DNA synthesis.

Formule : C₂₂H₁₈F₅N₃O₄

Degré de pureté : Min. 95%

Masse moléculaire : 483.39 g/mol

Ref: 3D-BE166807